TSXV:PSYB.H - Post by User
Post by
Betteryear2on Jul 21, 2023 10:37am
126 Views
Post# 35551414
Awarded Approval to Manufacture Biosynthetic Tryptamines
Awarded Approval to Manufacture Biosynthetic Tryptamines Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon discovery and development of novel, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, today announces that it has received government sanctioned, formal written approval to manufacture PsyBio's proprietary biosynthetic tryptamines. PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale (newsfilecorp.com)